SAN FRANCISCO, Sept. 25, 2020 /PRNewswire/ -- Why We Vaccinate, Inc., a 501(3)(c) educational organization dedicated to provide a credible and trusted source for honest and factual information on vaccines, their efficacy, safety and importance to public health, announced today the appointment of eight new board members. These additions to the organization's leadership further its efforts to develop educational programs and facts-based messages. Our goals are to put forward information on the science and safety of vaccines, educating the population on the value of all vaccines and immunization programs.
"The continuing expansion of our Board of Directors provides WhyWeVax with a diverse group of backgrounds, skills and experience from the academic, scientific, advocacy and Public Service fields. Our Board of Directors is committed to building WhyWeVax™'s visibility, credibility and value in the promotion of vaccines for the health of our communities, economy, friends and families," said Bill Hearl, Chairman of the Board of WhyWeVax™. "We are excited to leverage their talent, expertise and passion to further our mission."
The new Board members include:
Preston A. Englert (Tony)
Executive Director (Retired)
Ron and Joy Paul Kidney Center
The George Washington University
Nicole Fisher, D.P.H., M.P.P.
Founder and President
Health & Human Rights Strategies
Stephen Luber, M.D., F.A.S.C.
Associate Clinical Professor of Pediatrics
Assistant Professor Spokane Family Practice
University of Washington Medical School
Grace Rodden, J.D.
Senior Director, Federal Advocacy
Mark Salmon, Ph.D.
Department of Health, Behavior & Society
Bloomberg School of Public Health
Institute for Vaccine Safety
The Honorable Kathleen Kennedy Townsend
Director, Institute of Human Virology
University of Maryland
Griffin Group Advisors, LLC
Stefania Yanachkov J.D.
Vice President, External Affairs
Congressional Hispanic Caucus Institute
They join the founding Board Members that include:
William Hearl, Ph.D.
Co-Founder, Chairman, Board of Directors & CEO
Immunomix Therapeutics, Inc.
Athanasia (Sia) Anagnostou, M.B.A.
Secretary & Treasurer
Senior Director of Business Development
Immunomix Therapeutics, Inc.
Phyllis Arthur, Ph.D.
Vice President of Infectious Disease and Diagnostics Policy
Biotechnology Innovation Organization
Michael Olin Ph.D.
University of Minnesota Masonic Cancer Center
Department of Pediatrics
About Why We Vaccinate
WhyWeVax™ - www.whywevax.org - is a 501(3)(c) educational organization dedicated to provide a credible and trusted source for honest and factual information on vaccines, their efficacy, safety and importance to public health. WhyWeVax™ works to counter the misinformation, anti-science rhetoric and virulent fake news dissemination that question the safety and efficacy of vaccines for preventable infectious diseases. The development of a safe and effective vaccine for COVID-19 and its ultimate manufacture and distribution through the healthcare system will require a concerted effort by the biotechnology, academic, medical and scientific communities to meet the challenge of vaccine hesitancy and refusal. WhyWeVax™ will support educate the population to the value of vaccines to protect the health and safety of their families, their friends, their communities and our way of life.
Contact: Frank Howard, Jr.
Why We Vaccinate, Inc.
(202) 505-0506 (mobile)
SOURCE Why We Vaccinate, Inc.